Talaris Therapeutics   Report issue

For profit Phase 2 Phase 3
Founded: Louisville KY United States (2002)

Organization Overview

First Clinical Trial
2008
NCT00497926
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Talaris Therapeutics | Talaris Therapeutics Inc.